Eyelid margin debris removal

"Eyelid margin debris removal" is **not a molecular target** such as a receptor, enzyme, transporter, or gene. Instead, it refers to a **clinical procedure** aimed at removing accumulated material—such as bacterial biofilms, dead skin cells, sebum, and other debris—from the edge of the eyelids (the lid margin). This process is important in managing conditions like blepharitis and dry eye disease because bacteria can form resilient biofilms on the eyelid margins that contribute to chronic inflammation and dysfunction of meibomian glands[1][2]. Common methods include mechanical debridement using devices like BlephEx (a spinning sponge soaked in cleanser), ZEST (okra-based gel with enzymatic action), NuLids (oscillating brush head), manual expression with Q-tips after anesthetic application, or specialized probes for gland obstruction. These procedures aim to reduce microbial load and improve symptoms by restoring normal gland function and tear film quality[1][2][3]. Because "Eyelid margin debris removal" describes a therapeutic intervention rather than a discrete molecule or receptor targetable by drugs in the conventional sense—and lacks canonical molecular identifiers—it should not be classified as a therapeutic target.

Other names

Eyelid debris removalLid margin cleaningEyelid hygieneBiofilm removal (eyelid)

Mechanical removal of biofilm and debris from eyelid margin[1][2][3] - Exfoliation of lid margin to reduce bacterial load and biofilm[1][3]